<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SpineJournal.gr &#124; Spine Industry News</title>
	<atom:link href="http://www.spinejournal.gr/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.spinejournal.gr</link>
	<description>Exclusively Spine</description>
	<lastBuildDate>Wed, 16 May 2012 17:20:47 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
		<item>
		<title>Is it time to update your social media policy?</title>
		<link>http://www.spinejournal.gr/2012/05/is-it-time-to-update-your-social-media-policy/</link>
		<comments>http://www.spinejournal.gr/2012/05/is-it-time-to-update-your-social-media-policy/#comments</comments>
		<pubDate>Wed, 16 May 2012 17:20:47 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Social Media 101]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[social media policy]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2532</guid>
		<description><![CDATA[By Karen M. Cheung With the Federation of State Medical Boards (FSMB) this week releasing new guidelines for physicians on this particular topic, FierceHealthcare is dedicating this week&#8217;s commentary to a round-up of the best practices to help hospitals draw on other policies to see what fits at their institutions. A new physician at the hospital just sent [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/is-it-time-to-update-your-social-media-policy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health-Care Economies of Scale</title>
		<link>http://www.spinejournal.gr/2012/05/health-care-economies-of-scale/</link>
		<comments>http://www.spinejournal.gr/2012/05/health-care-economies-of-scale/#comments</comments>
		<pubDate>Wed, 16 May 2012 16:44:53 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[health care economies]]></category>
		<category><![CDATA[medicare]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2558</guid>
		<description><![CDATA[By Alex Wayne on March 22, 2012Only 1 of 10 cost-control efforts attempted by Medicare over two decades has saved the government money, the Congressional Budget Office (CBO) reported in January. Richard Gilfillan, head of the most ambitious attempt yet, says he can get over that very low bar. Gilfillan runs the $10 billion Center for Medicare [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/health-care-economies-of-scale/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bone Graft Options for Spine Fusion Surgery</title>
		<link>http://www.spinejournal.gr/2012/05/bone-graft-options-for-spine-fusion-surgery/</link>
		<comments>http://www.spinejournal.gr/2012/05/bone-graft-options-for-spine-fusion-surgery/#comments</comments>
		<pubDate>Wed, 16 May 2012 16:09:15 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Spine Health Tips]]></category>
		<category><![CDATA[BMP]]></category>
		<category><![CDATA[Bone Graft Options]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[Osteoconduction]]></category>
		<category><![CDATA[Osteogenicity]]></category>
		<category><![CDATA[Osteoinduction]]></category>
		<category><![CDATA[Scott D. Boden]]></category>
		<category><![CDATA[Spine Fusion Surgery]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2528</guid>
		<description><![CDATA[By: Scott D. Boden, MD source&#62;&#62;&#62; To achieve a solid spine fusion, three processes are necessary: Osteoconduction—this refers to the scaffolding that is needed for new bone to grow on. Osteogenicity—this refers to the transmittal of live bone cells or osteoblasts Osteoinduction—this is the process whereby specific proteins such as bone morphogenetic proteins (BMPs) induce the [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/bone-graft-options-for-spine-fusion-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives</title>
		<link>http://www.spinejournal.gr/2012/05/regenerative-sciences-receives-2m-investment-for-orthopedic-stem-cell-initiatives/</link>
		<comments>http://www.spinejournal.gr/2012/05/regenerative-sciences-receives-2m-investment-for-orthopedic-stem-cell-initiatives/#comments</comments>
		<pubDate>Wed, 16 May 2012 16:02:35 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[Regenerative Sciences]]></category>
		<category><![CDATA[stem cell]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2523</guid>
		<description><![CDATA[Funding Will Support Research, Development, and Availability of Next Generation Non-Surgical Stem Cell Treatments DENVER, May 14, 2012 /PRNewswire/ &#8212; Regenerative Sciences, Inc., a company dedicated to advancing orthopedic care through non-surgical adult stem cell procedures, today announced that it has secured a $2M investment from philanthropist, visionary and businessman John C. Malone, PhD, chairman of Liberty Media Corporation. In [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/regenerative-sciences-receives-2m-investment-for-orthopedic-stem-cell-initiatives/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prolonged Bed Rest as Adjuvant Therapy After Complex Reconstructive Spine Surgery</title>
		<link>http://www.spinejournal.gr/2012/05/prolonged-bed-rest-as-adjuvant-therapy-after-complex-reconstructive-spine-surgery/</link>
		<comments>http://www.spinejournal.gr/2012/05/prolonged-bed-rest-as-adjuvant-therapy-after-complex-reconstructive-spine-surgery/#comments</comments>
		<pubDate>Wed, 16 May 2012 13:38:18 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Publications]]></category>
		<category><![CDATA[Prolonged Bed Rest]]></category>
		<category><![CDATA[Rex A. W. Marco MD]]></category>
		<category><![CDATA[Ryan M. Stuckey MD]]></category>
		<category><![CDATA[Stephanie P. Holloway MHA]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2556</guid>
		<description><![CDATA[Rex A. W. Marco MD, Ryan M. Stuckey MD, Stephanie P. Holloway MHA Symposium: Complications of Spine Surgery Volume 470, Issue 6 / June , 2012 Abstract Background The benefits of postoperative mobilization include decreased incidence of pulmonary complications, pressure ulcers, and progression of deep vein thrombosis. However, the complexity of certain spinal reconstructions and the [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/prolonged-bed-rest-as-adjuvant-therapy-after-complex-reconstructive-spine-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic Mutation Causing Rare Form of Spinal Muscular Atrophy Identified</title>
		<link>http://www.spinejournal.gr/2012/05/genetic-mutation-causing-rare-form-of-spinal-muscular-atrophy-identified/</link>
		<comments>http://www.spinejournal.gr/2012/05/genetic-mutation-causing-rare-form-of-spinal-muscular-atrophy-identified/#comments</comments>
		<pubDate>Sat, 12 May 2012 19:26:05 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Clinical Studies]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[muscle degeneration]]></category>
		<category><![CDATA[Robert H. Baloh]]></category>
		<category><![CDATA[SMA-LED]]></category>
		<category><![CDATA[Spinal muscular atrophy]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2520</guid>
		<description><![CDATA[ScienceDaily (May 10, 2012) — Scientists have confirmed that mutations of a gene are responsible for some cases of a rare, inherited disease that causes progressive muscle degeneration and weakness: spinal muscular atrophy with lower extremity predominance, also known as SMA-LED.&#8220;Typical spinal muscular atrophies begin in infancy or early childhood and are fatal, involving all motor [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/genetic-mutation-causing-rare-form-of-spinal-muscular-atrophy-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>When doctors are forced to accept malpractice case settlements</title>
		<link>http://www.spinejournal.gr/2012/05/when-doctors-are-forced-to-accept-malpractice-case-settlements/</link>
		<comments>http://www.spinejournal.gr/2012/05/when-doctors-are-forced-to-accept-malpractice-case-settlements/#comments</comments>
		<pubDate>Sat, 12 May 2012 19:18:35 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Spine Health Tips]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[insurance policy]]></category>
		<category><![CDATA[malpractice]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2517</guid>
		<description><![CDATA[by WILLIAM SULLIVAN, DO, JD Suppose your malpractice insurance company wants to settle a medical malpractice case against you – even though the case has no merit. In many cases, insurance policy language may allow the insurance company to do just that. In the 2011 case of Mohan Papudesu, MD v. Medical Malpractice Joint Underwriting Assn. of [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/when-doctors-are-forced-to-accept-malpractice-case-settlements/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How Do Clinical Trials Work?</title>
		<link>http://www.spinejournal.gr/2012/05/how-do-clinical-trials-work/</link>
		<comments>http://www.spinejournal.gr/2012/05/how-do-clinical-trials-work/#comments</comments>
		<pubDate>Sat, 12 May 2012 19:12:50 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Spine Health Tips]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[featured]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2512</guid>
		<description><![CDATA[Clinical trials are research studies to test ways to detect, prevent or treat disease. You might have a family member involved in a clinical trial, or you might be considering whether a clinical trial is an option for you. Choosing to participate in a clinical trial can be a complex decision. You first need to [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/how-do-clinical-trials-work/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Possible Cause of Movement Defects in Spinal Muscular Atrophy Identified</title>
		<link>http://www.spinejournal.gr/2012/05/possible-cause-of-movement-defects-in-spinal-muscular-atrophy-identified/</link>
		<comments>http://www.spinejournal.gr/2012/05/possible-cause-of-movement-defects-in-spinal-muscular-atrophy-identified/#comments</comments>
		<pubDate>Sun, 06 May 2012 09:35:21 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Clinical Studies]]></category>
		<category><![CDATA[Christine Beattie]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Spinal muscular atrophy]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2508</guid>
		<description><![CDATA[ScienceDaily  — An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests. Spinal muscular atrophy, or SMA, is caused when a child&#8217;s motor neurons &#8212; nerve cells that send signals from the spinal cord to [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/possible-cause-of-movement-defects-in-spinal-muscular-atrophy-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetically Engineered Compound for Back Pain Falls Short</title>
		<link>http://www.spinejournal.gr/2012/05/genetically-engineered-compound-for-back-pain-falls-short/</link>
		<comments>http://www.spinejournal.gr/2012/05/genetically-engineered-compound-for-back-pain-falls-short/#comments</comments>
		<pubDate>Sun, 06 May 2012 09:26:04 +0000</pubDate>
		<dc:creator>Akillas</dc:creator>
				<category><![CDATA[Clinical Studies]]></category>
		<category><![CDATA[Enbrel]]></category>
		<category><![CDATA[Etanercept]]></category>
		<category><![CDATA[featured]]></category>
		<category><![CDATA[john Hopkins]]></category>
		<category><![CDATA[Steven P. Cohen]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=2504</guid>
		<description><![CDATA[ScienceDaily — Despite the great promise that injecting a new type of anti-inflammatory pain medicine into the spine could relieve the severe leg and lower back pain of sciatica, a Johns Hopkins-led study has found that the current standard of care with steroid injections still does better. Etanercept, sold by the brand-name Enbrel, is a [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2012/05/genetically-engineered-compound-for-back-pain-falls-short/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

